VTRS

Nasdaq

Viatris Inc

Health Care, Pharmaceuticals

$16.43

close 7 Aug 2026

+66.63%

52-week change

$18.87B

market cap

$9.43

$18.39

52-week range

Valuation

Market cap$18.87B

P/E (TTM / 5y avg)-47.53x46.79x

Forward P/E (FY2026 / FY2027)6.66x6.22x

PEG (TTM / fwd)—0.94

P/S (TTM)1.28x

P/B1.32x

EV/EBITDA (TTM)11.56x

FCF yield (TTM)10.36%

Cash flow & dividend

FCF (TTM)$1.95B

FCF per share (TTM)$1.70

FCF margin (TTM)13.26%

Dividend yield (indicated / 5y avg)2.92%4.26%

Annualized dividend$0.4800

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+4.88%

Diluted EPS YoY, latest Q—

Operating margin (TTM)-0.59%

Net margin (TTM)-2.79%

ROE (latest FY)-23.89%

Net debt / EBITDA (TTM)4.60

Interest coverage (TTM)-0.18

Price

+9.90%+1.91%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +3.66%

Diluted EPS

FCF per share

5Y CAGR +0.18%

Operating cash flow

5Y CAGR +13.46%

Free cash flow

5Y CAGR +14.40%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR +14.19%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date4 Nov 2026

EPS estimate$0.6608

Revenue estimate$3.90B

Last reported

Date—

EPS——

Revenue——